This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety and efficacy of TRC4186 in the treatment of...
Clinical trial

Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failure.

Read time: 1 mins
Last updated:20th Jul 2009
To evaluate safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c ? 6% or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failure (Proof of Concept).
Category Value
Study start date 2009-07-20

View full details